Valuation: Dechra Pharmaceuticals

Market Cap 4.4B 5.77B 5.25B 4.84B 8.26B 534B 8.68B 58.92B 23.42B 292B 21.64B 21.19B 916B P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 4.83B 6.33B 5.77B 5.31B 9.07B 586B 9.53B 64.67B 25.7B 320B 23.76B 23.26B 1,005B EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,814
Extreme 3814
3,868
5 years 2,473.32
Extreme 2473.323
5,395
10 years 1,225
Extreme 1225
5,525
Manager TitleAgeSince
Chief Executive Officer - 10/06/2024
Director of Finance/CFO 46 03/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 30/10/2019
Director/Board Member 68 01/12/2016
Director/Board Member 59 01/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/1/24 Free

Chief Executive Officer

18,551 0.0163%
15/1/24 Free

Chief Financial Officer

2,293 0.0020%
15/1/24 Buy

Chief Executive Officer

627 0.0006%

Financials

2022 2023
Net sales 682M 893M 813M 750M 1.28B 82.7B 1.34B 9.12B 3.63B 45.17B 3.35B 3.28B 142B 762M 997M 909M 837M 1.43B 92.37B 1.5B 10.19B 4.05B 50.45B 3.74B 3.66B 158B
Net income 58.2M 76.24M 69.44M 63.98M 109M 7.06B 115M 779M 309M 3.86B 286M 280M 12.1B -27.9M -36.55M -33.29M -30.67M -52.34M -3.38B -55.01M -373M -148M -1.85B -137M -134M -5.8B
Net Debt 208M 273M 248M 229M 391M 25.25B 411M 2.79B 1.11B 13.79B 1.02B 1B 43.29B 430M 563M 513M 473M 807M 52.17B 848M 5.75B 2.29B 28.5B 2.11B 2.07B 89.43B
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-